Viva Biotech Holdings (VB0) — Free Cash Flow Generation Index
Viva Biotech Holdings (VB0) has a Free Cash Flow Generation Index of 1.32x as of June 2023. Free cash flow of €209.53 Million represents 1% of operating cash flow (€158.72 Million). Read Viva Biotech Holdings balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Viva Biotech Holdings Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Viva Biotech Holdings across 9 annual periods. Explore Viva Biotech Holdings capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Viva Biotech Holdings (2016–2024)
Year-by-year Free Cash Flow Generation Index for Viva Biotech Holdings. For the full company profile including market capitalisation, see Viva Biotech Holdings market cap and net worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.49x | €182.32 Million | €373.99 Million | €191.67 Million | ▼ -4.4% |
| 2023 | 0.51x | €195.57 Million | €383.40 Million | €187.84 Million | ▲ +44.3% |
| 2022 | 0.35x | €136.51 Million | €386.05 Million | €249.33 Million | ▲ +105.6% |
| 2021 | -6.28x | €-488.49 Million | €77.83 Million | €565.18 Million | ▲ +53.7% |
| 2020 | -13.56x | €-585.70 Million | €43.18 Million | €592.62 Million | ▼ -3846.2% |
| 2019 | -0.34x | €-15.81 Million | €46.01 Million | €56.19 Million | ▲ +88.0% |
| 2018 | -2.87x | €-34.79 Million | €12.11 Million | €46.90 Million | ▼ -993.5% |
| 2017 | 0.32x | €8.97 Million | €27.89 Million | €18.92 Million | ▼ -76.1% |
| 2016 | 1.35x | €28.46 Million | €21.12 Million | €7.34 Million | — |